Các chất ức chế kinaza phụ thuộc cyclin G1 ở động vật có vú.

Genes and Development - Tập 9 Số 10 - Trang 1149-1163 - 1995
Charles J. Sherr1, James M. Roberts
1Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38104, USA.

Tóm tắt

Kinaza phụ thuộc cyclin (CDK) là những enzyme quan trọng trong việc điều hòa chu kỳ tế bào của động vật có vú, đặc biệt là trong giai đoạn G1. Việc phát triển và phát hiện các chất ức chế CDK đã tạo ra nền tảng quan trọng trong nghiên cứu điều trị ung thư vì khả năng ngăn chặn sự phân chia tế bào bất thường. Các chất ức chế CDK đã được chứng minh có tiềm năng can thiệp vào tiến trình chu kỳ tế bào và được xem như là một chiến lược trị liệu hấp dẫn. Bài báo này bàn luận về cấu trúc hóa học, cơ chế hoạt động của các chất ức chế CDK G1 cũng như tiềm năng ứng dụng lâm sàng của chúng.

Từ khóa

#kinaza phụ thuộc cyclin #G1 #chất ức chế CDK #chu kỳ tế bào động vật có vú #điều trị ung thư

Tài liệu tham khảo

1993, Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes., J. Biol. Chem., 268, 4113, 10.1016/S0021-9258(18)53587-0

10.1101/gad.7.5.812

1994, CDK6 (PLSTIRE) and CDK4 (PSKJ3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1., Oncogene, 9, 71

1994, Absence of cyclin D/cdk4 complexes in cells lacking functional retinoblastoma protein., Oncogene, 9, 1633

1995, Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kipl, to regions involved in human cancer., Cancer Res., 55, 1199

10.1038/370220a0

1994, Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma., Nature Genet., 8, 27, 10.1038/ng0994-27

10.1101/gad.9.5.600

10.1126/science.1439824

1995, Identification of human/mouse p19, a novel cdk4/cdk6 inhibitor with homology to p16ink4., Mol. Cell. Biol., 15, 2682, 10.1128/MCB.15.5.2682

10.1038/374386a0

10.1038/359328a0

10.1038/362849a0

1990, Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types., Oncogene, 5, 1731

10.1101/gad.7.4.546

10.1101/gad.8.21.2540

10.1016/0092-8674(93)90137-F

10.1126/science.1329201

10.1073/pnas.90.23.11034

10.1016/0092-8674(94)90379-4

10.1016/0092-8674(93)90500-P

1994, WAF1/Cip1 is induced in p53-mediated G1 arrest and apoptosis., Cancer Res., 54, 1169

10.1016/0092-8674(93)90136-E

10.1016/0092-8674(93)90723-4

10.1101/gad.9.2.204

1994, Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes., Mol. Cell. Biol., 14, 4889

10.1016/0092-8674(94)90535-5

10.1073/pnas.91.18.8655

10.1016/0092-8674(93)90110-C

10.1038/366707a0

10.1101/gad.8.24.2939

10.1126/science.7863327

1993, Speculations on the roles of RBI in tissue-specific differentiation, tumor initiation, and tumor progression., FASEB J., 7, 846, 10.1096/fasebj.7.10.8344484

10.1038/371257a0

10.1016/0092-8674(93)90499-G

10.1091/mbc.6.4.387

10.1038/364501a0

10.1101/gad.8.15.1759

10.1006/bbrc.1994.2090

1994, Candidate tumor suppressor MTS1 (p16INK4A) and MTS2 (pl5INK4B) display frequent homozygous deletions in primary cells from T- but not B-cell lineage acute lymphoblastic leukemias., Blood, 84, 4038, 10.1182/blood.V84.12.4038.bloodjournal84124038

10.1073/pnas.91.12.5291

10.1016/0959-437X(94)90102-3

10.1016/0092-8674(92)90249-C

1995, Novel INK4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6., Mol. Cell. Biol., 15, 2672, 10.1128/MCB.15.5.2672

1994, The transcription factor, the cdk, its cyclin and their regulator: Directing the transcriptional response to a nutritional signal., EMBO J., 13, 5410, 10.1002/j.1460-2075.1994.tb06876.x

10.1016/0092-8674(94)90543-6

1994, Germline p16 mutations in familial melanoma., Nature Genet., 8, 15, 10.1038/ng0994-15

10.1038/359295a0

1994, Deletion of p16 and p15 genes in brain tumors., Cancer Res., 24, 6353

1994, Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53., Oncogene, 9, 3397

10.1126/science.8108735

10.1126/science.8153634

10.1038/ng0994-22

1991, Participation of p53 protein in the cellular response to DNA damage., Cancer Res., 51, 6304

10.1016/0092-8674(92)90593-2

10.1073/pnas.90.24.11513

10.1101/gad.7.3.331

10.1016/0092-8674(94)90257-7

10.1128/MCB.14.4.2713

10.1016/0092-8674(94)90239-9

10.1016/0092-8674(91)90044-Y

10.1126/science.1388288

10.1126/science.8475385

10.1126/science.8469989

10.1038/316330a0

10.1073/pnas.89.16.7491

10.1038/359288a0

10.1101/gad.9.6.639

10.1016/0092-8674(91)90042-W

10.1038/371534a0

1994, Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21., Oncogene, 9, 2261

10.1016/0092-8674(92)90243-6

1993, Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents., Blood, 82, 1092, 10.1182/blood.V82.4.1092.1092

10.1038/362847a0

10.1073/pnas.91.6.2026

10.1016/0092-8674(93)90496-D

10.1083/jcb.125.3.625

1995, Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells, independent of CDK4 activity., Mol. Cell. Biol., 15, 2600, 10.1128/MCB.15.5.2600

Lukas, J., Parry, D. Aagaard, L. Mann, D.J. Bartkova, J. Strauss, M. Peters, G. and Bartek. J. 1995b. Retinoblastoma protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (in press).

Luo, Y., Hurwitz, J. and Massagué. J. 1995. Cell cycle inhibition mediated by functionally independent CDK and PCNA inhibitory domains in p21CIP1. Nature (in press).

10.1038/371254a0

10.1101/gad.5.2.151

1994, Activation of cyclin-dependent kinase-4 (CDK4) by mouse M015-associated kinase., Mol. Cell. Biol., 14, 7265

10.1101/gad.9.6.650

10.1016/0092-8674(91)90101-4

10.1016/0092-8674(92)90360-O

1994, D-type cyclin-dependent kinase activity in mammalian cells., Mol. Cell. Biol., 14, 2066

Medema, R., Herrera, R.E. Lam, F. and Weinberg. R.A. 1995. Growth suppression by p16INK4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. (in press).

1994, Identification of a G1 kinase activity for cdk6, a novel cyclin D partner., Mol. Cell. Biol., 14, 2077

1994, Inhibition of WAF1/CIP1 by a p53-independent pathway., Cancer Res., 54, 3391

1994, Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases cdk4 and cdk42 in human T cells., J. Biol. Chem., 52, 32972

10.1038/371072a0

1994, Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma., Cancer Res., 54, 3396

10.1073/pnas.91.8.2945

1995, Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1., EMBO J., 14, 555, 10.1002/j.1460-2075.1995.tb07031.x

10.1126/science.1411535

10.1038/368753a0

10.1006/excr.1994.1063

10.1038/372570a0

10.1126/science.8384376

1995, Human cyclin E, a nuclear protein essential for the G1 to S phase transition., Mol. Cell. Biol., 15, 2612, 10.1128/MCB.15.5.2612

10.1073/pnas.91.23.11045

1995, Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia., Blood, 85, 2321, 10.1182/blood.V85.9.2321.bloodjournal8592321

1994, Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB., Oncogene, 9, 3375

10.1101/gad.8.11.1285

10.1126/science.2683075

10.1126/science.7863329

1995, Lack of cyclin D-cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumor suppressor gene product., EMBO J., 14, 503, 10.1002/j.1460-2075.1995.tb07026.x

10.1038/371204a0

1995, Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias., Cancer Res., 55, 1206

10.1016/0968-0004(93)90185-P

10.1101/gad.8.1.9

10.1016/0092-8674(94)90572-X

1995, p27Kip1 chromosomal mapping to 12p12 and absence of mutations in human tumors., Cancer Res., 55, 1211

10.1073/pnas.91.23.10918

10.1101/gad.7.8.1559

Ranade, K., Hussassian, C.J. Sikorski, R.S. Varmus, H.E. Goldstein, A.M. Tucker, M.A. Serrano, M. Hannon, G.J. Beach, D. and Dracopoli. N.C. 1995. Mutations associated with familial melanoma impair p16INK4 function. Nature Genet. (in press).

1994, Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic-loop-helix regulators., Mol. Cell. Biol., 14, 5259

Resnitzky, D. and Reed. S. 1995. Different roles for cyclins D1 and E in regulation of the G1 to S transition. Mol. Cell. Biol. (in press).

10.1128/MCB.14.3.1669

1994, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas., Cancer Res., 54, 6321

10.1126/science.8197461

10.1126/science.7939631

10.1038/366704a0

10.1126/science.7809631

10.1016/S0960-9822(95)00009-1

1994, Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: Role of p53-dependent and independent signal transduction pathways., Oncogene, 9, 3407

1993, Mammalian G1 cyclins., Cell, 73, 1059, 10.1016/0092-8674(93)90636-5

10.1016/0092-8674(94)90540-1

10.1016/0962-8924(94)90033-7

10.1016/S0960-9822(00)00244-X

10.1126/science.7863328

10.1073/pnas.91.12.5320

1994, A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells., Mol. Cell. Biol., 14, 3683

1994, Induction of p21(WAF-1/CIP1) during differentiation., Oncogene, 9, 3389

10.1016/S0960-9822(00)00196-2

10.1016/0092-8674(94)90534-7

1994, Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16INK4., Cancer Res., 54, 5816

1994, Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: Association with cdk4 is required for cyclin D1 function in G1 progression., Oncogene, 9, 2663

10.1091/mbc.4.7.705

10.1016/0092-8674(94)90573-8

10.1126/science.8266103

10.1038/369574a0

10.1101/gad.8.23.2817

10.1016/S0960-9822(95)00058-3

10.1126/science.1659741

10.1073/pnas.91.9.3602

10.1016/0092-8674(92)90518-H

10.1101/gad.7.8.1572

10.1038/366701a0

Yang, R., Serrano, M. and Koeffler. P. 1995. Mutational effects of the p16INK4a tumor supressor protein. Cancer Res. (in press).

10.1016/0092-8674(92)90244-7

10.1038/352345a0

10.1091/mbc.4.9.897

10.1101/gad.8.15.1750